Literature DB >> 9293031

New pharmaceuticals from marine organisms.

W Fenical1.   

Abstract

Definitions of 'marine biotechnology' often refer to the vast potential of the oceans to lead to new cures for human and animal disease; the exploitation of natural drugs has always been the most basic form of biotechnology. Although only initiated in the late 1970s, natural drug discovery from the world's oceans has been accelerated by the chemical uniqueness of marine organisms and by the need to develop drugs for contemporary, difficult to cure, diseases. Current research activities, while primarily within the academic laboratories, have generated convincing evidence that marine drug discovery has an exceedingly bright future.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9293031     DOI: 10.1016/S0167-7799(97)01081-0

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  17 in total

Review 1.  Search and discovery strategies for biotechnology: the paradigm shift.

Authors:  A T Bull; A C Ward; M Goodfellow
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

2.  Evaluation of methods for storage of marine macroorganisms with optimal recovery of bacteria.

Authors:  Kathrin Siebert; Martina Busl; Irina Asmus; Josef Freund; Albrecht Muscholl-Silberhorn; Reinhard Wirth
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

3.  Genome sequence analysis and bioactivity profiling of marine-derived actinobacteria, Brevibacterium luteolum, and Cellulosimicrobium funkei.

Authors:  Faouzia Tanveer; Muhammad Shehroz; Muhammad Ali; Yunying Xie; Rashda Abbasi; Zabta Khan Shinwari; Azra Yasmin
Journal:  Arch Microbiol       Date:  2021-03-07       Impact factor: 2.552

Review 4.  Therapeutic applications of bacterial pigments: a review of current status and future opportunities.

Authors:  Muhammad Numan; Samina Bashir; Roqayya Mumtaz; Sibgha Tayyab; Najeeb Ur Rehman; Abdul Latif Khan; Zabta Khan Shinwari; Ahmed Al-Harrasi
Journal:  3 Biotech       Date:  2018-04-04       Impact factor: 2.406

5.  Penilumamide, a novel lumazine peptide isolated from the marine-derived fungus, Penicillium sp. CNL-338.

Authors:  Sven W Meyer; Thorsten F Mordhorst; Choonghwan Lee; Paul R Jensen; William Fenical; Matthias Köck
Journal:  Org Biomol Chem       Date:  2010-03-11       Impact factor: 3.876

6.  Cytotoxic cyplasin of the sea hare, Aaplysia punctata, cDNA cloning, and expression of bioactive recombinants in insect cells.

Authors:  Christian Petzelt; Gaby Joswig; Hermann Stammer; Dieter Werner
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

7.  Purification and partial identification of novel antimicrobial protein from marine bacterium Pseudoalteromonas species strain X153.

Authors:  Arlette Longeon; Jean Peduzzi; Michel Barthélemy; Sophie Corre; Jean-Louis Nicolas; Michéle Guyot
Journal:  Mar Biotechnol (NY)       Date:  2004 Nov-Dec       Impact factor: 3.619

Review 8.  Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections.

Authors:  Morten Hentzer; Michael Givskov
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  The current status of natural products from marine fungi and their potential as anti-infective agents.

Authors:  Punyasloke Bhadury; Balsam T Mohammad; Phillip C Wright
Journal:  J Ind Microbiol Biotechnol       Date:  2006-01-21       Impact factor: 4.258

10.  Pyramidamycins A-D and 3-hydroxyquinoline-2-carboxamide; cytotoxic benzamides from Streptomyces sp. DGC1.

Authors:  Khaled A Shaaban; Micah D Shepherd; Tamer A Ahmed; S Eric Nybo; Markos Leggas; Jürgen Rohr
Journal:  J Antibiot (Tokyo)       Date:  2012-10-10       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.